This is the first report in a series commissioned by the Baltimore City Health Department exploring whether the expansion of buprenorphine as a strategy for battling opioid addiction is cost-effective. This report uses Medicaid data to examine health care service utilization differences between opioid addicts who were treated for this condition versus addicts who were not.